#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Intracranial germ cell tumour Non-Hodgkin's lymphoma unspecified histology aggressive recurrent Spinal muscular atrophy Severe myoclonic epilepsy of infancy Retinopathy proliferative Meningococcal immunisation Acute promyelocytic leukaemia Neuroendocrine carcinoma of the skin Oesophageal squamous cell carcinoma stage II Human papilloma virus immunisation Dementia Alzheimer's type Synovial sarcoma Chronic myeloid leukaemia Pituitary-dependent Cushing's syndrome Primary adrenal insufficiency More trials…

    Learn about Rare Diseases

    Angelman’s syndrome Progressive multifocal leukoencephalopathy – Diagnostics Langerhans’ cell histiocytosis – Treatment Splenic marginal zone lymphoma – Diagnostics Glomerulonephritis rapidly progressive Splenic marginal zone lymphoma Mucopolysaccharidosis III – Basic Information Mantle cell lymphoma stage II – Life with Disease Choroid melanoma – Life with Disease Soft tissue sarcoma – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Rbd4059 Hypothalamic Phospholipids SAT-3247 OXALATE Eribulin Mesylate Baclofen ARLOCABTAGENE AUTOLEUCEL Tenecteplase Cilazapril Nifedipine Metronidazole Azd0305 Nicotine Cemiplimab NORETHISTERONE ACETATE Nms-03592088 Pilocarpine Nitrate Hydroxyzine Hydrochloride Palmidrol 68Ganota-Anti-Her2 Vhh1 Pyridoxine More therapies…

    Learn about Your Condition

    Pancreatitis chronic Acute lymphocytic leukaemia Friedreich's ataxia Hypochromic anaemia Small intestine adenocarcinoma Rosai-Dorfman syndrome Labour pain Medullary thyroid cancer Lung cancer metastatic Head injury Metastases to biliary tract Spinal cord injury cervical Cardiovascular disorder Nocturia Peyronie's disease More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Marien Hospital Herne Universitätsklinikum der Ruhr-Universität…

Marien Hospital Herne Universitätsklinikum der Ruhr-Universität Bochum

Hoelkeskampring 40, Herne, 44625, Germany

Want to learn more about this study or check if you can participate? Contact us.

  • Study of Adagrasib and Cetuximab for Patients with Advanced Colorectal Cancer with KRAS G12C Mutation After First-Line Therapy

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Adagrasib
    • Aflibercept
    • Bevacizumab
    Austria Belgium Czechia Denmark Finland France +9

  • Study Comparing Enfortumab Vedotin and Pembrolizumab with Chemotherapy for Patients with Muscle-Invasive Bladder Cancer

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Cisplatin
    • Gemcitabine
    • Pembrolizumab
    Bulgaria Croatia Czechia France Germany Greece +6

  • Study on Andexanet Alfa for Patients on Factor Xa Inhibitors (Apixaban, Rivaroxaban, Edoxaban) Needing Urgent Surgery to Reduce Bleeding Risk

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Aminocaproic Acid
    • Blood And Related Products
    • Etamsylate
    Austria Belgium Bulgaria Czechia Denmark Estonia +13

  • Study on the Effectiveness and Safety of AP707 and Naproxen for Patients with Chronic Back Pain

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Back pain
    Investigated Drugs:
    • Aceclofenac
    • Acemetacin
    • Acetylsalicylic Acid
    Austria Germany

  • Study on the Effectiveness of AP707, Gabapentin, and Capsaicin for Patients with Chronic Pain from Traumatic or Post-Operative Peripheral Neuropathy

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Neuropathy peripheral
    • Pain
    Investigated Drugs:
    • Adezunap
    • Amitriptyline
    • Buclizine Hydrochloride
    Austria Germany

  • Study on the Effectiveness and Safety of AP707 with Lamotrigine and Amitriptyline for Patients with Chronic Central Neuropathic Pain

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Neuropathy peripheral
    • Pain
    Investigated Drugs:
    • Adezunap
    • Amitriptyline
    • Buclizine Hydrochloride
    Austria Germany

  • Study Comparing Docetaxel, Darolutamide, and ADT for Patients with Metastatic Hormone-Sensitive Prostate Cancer

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Buserelin Acetate
    • Degarelix
    • Leuprorelin Acetate
    Austria Germany

  • Study on the Effectiveness and Safety of AP707, Amitriptyline, and Capsaicin for Patients with Chronic Pain from Diabetic Neuropathy

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Diabetic neuropathy
    • Pain
    Investigated Drugs:
    • Carbamazepine (Ph. Eur.)
    • Paracetamol Dc
    • Anhydrous Caffeine
    Austria Germany
Previous Page
1 2 3

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!